NRG Oncology hosts two SemiAnnual Meetings each year. The meeting consists of many sessions and workshops to provide an exchange of information concerning current research, establish criteria for the evaluation of protocol compliance, and review research progress.
The targeted audiences are members and nonâ€members of the NRG research teams to include: Gynecologic Oncologists, Medical Oncologists, Radiation Oncologists, Pathologists, and other MDs engaged in oncology research and/or clinical practice; Oncology Nurses, Nurseâ€practitioners, and other interested Allied Health professionals. The speakers will focus their presentations on the mechanism by which cancer escapes the immune system. Presentations will also be focused on current and future strategies developing immunotherapies that address such mechanisms for good clinical outcomes.
This meeting will draw approximately 1500 meeting attendees, providing a unique opportunity to reach a significant cross section of the clinical oncology research community.
The purpose of the exhibits is to give companies an opportunity to inform the membership about drugs, technologies, supplies and services that are available to oncology researchers.
Each Exhibiting Company will receive a complimentary listing in the Final Agenda Program. This program will be distributed to over 1500 meeting attendees.
About NRG Oncology:
NRG Oncology is a non-profit research organization formed to conduct oncologic clinical research and to broadly disseminate study results for informing clinical decision making and healthcare policy. It brings together the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG) - each recognized internationally as a research leader.